BluGlass (ASX:BLG) has received a AU$1.4 million phase two funding commitment from US photonics company Uviquity as part of their ongoing joint development agreement, according to a Thursday Australian bourse filing.
The expanded collaboration will advance Uviquity's deep-UV photonic integrated circuit platform through wafer and chip processing, packaging, laser integration, and the supply of BluGlass' visible gallium nitride laser products, per the filing.
The program builds on the success of its first phase by advancing Uviquity's chip-scale deep-UV laser technology for applications across semiconductor, pharmaceutical, environmental, defense, and disinfection sectors, the filing said.
Payments will be made in instalments throughout the next year, beginning in the third quarter, the filing added.
The company's shares jumped 13% in recent Thursday trade.